Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome

Arthritis and Rheumatism

Volumn 43, Issue 7, 2000, Pages 1647-1654

  Waterman, Sally A ^a   Gordon, Tom P ^b   Rischmueller, Maureen ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; AUTOANTIBODY; CARBACHOL; IMMUNOGLOBULIN G; MUSCARINIC M3 RECEPTOR; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; AUTONOMIC DYSFUNCTION; BLADDER MUSCLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DRY EYE; FEMALE; HUMAN; LACRIMAL GLAND; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND; SERUM; SJOEGREN SYNDROME; SMOOTH MUSCLE CONTRACTION; SYSTEMIC LUPUS ERYTHEMATOSUS; XEROSTOMIA;

ACETYLCHOLINE; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; AUTOANTIBODIES; CARBACHOL; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MIDDLE AGED; MUSCARINIC AGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTOR, MUSCARINIC M3; RECEPTORS, MUSCARINIC; SJOGREN'S SYNDROME; SYNAPTIC TRANSMISSION; URINARY BLADDER;

EID: 0033948273     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P     Document Type: Article

References (33)

1. Moutsopoulos HM, Webber BL, Vlagopoulos TP, Chused TM, Decker JL. Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med 1979;66:733-6.
2. Fox RI. Sjögren's syndrome. Curr Opin Rheumatol 1995;7:409-16.
3. Fox RI, Tornwall J, Maruyama T, Stern M. Evolving concepts of diagnosis, pathogenesis and therapy of Sjögren's syndrome. Curr Opin Rheumatol 1998;10:446-56.
4. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci U S A 1998;95:7538-43.
5. Yamamoto H, Sims NE, Macauley SP, Nguyen K-HT, Nakagawa Y, Humphreys-Beher MG. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 1996;78:245-55.
6. 3 muscarinic receptors in primary Sjögren's syndrome. Clin Exp Immunol 1996;104:454-9.
7. 3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci 1998;39:151-6.
8. Bachmeyer C, Zuber M, Dupont S, Blanche P, Dhote R, Mas JL. Adie syndrome as the initial sign of primary Sjögren's syndrome. Am J Ophthalmol 1997;123:691-2.
9. Font J, Valls J, Cervera R, Pou A, Ingelmo M, Graus F. Pure sensory neuropathy in patients with primary Sjögren's syndrome: clinical, immunological, and electromyographic findings. Ann Rheum Dis 1990;49:775-8.
10. Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol 1990;27:304-15.
11. Katz JS, Houroupian D, Ross MA. Multisystem neuronal involvement and sicca complex: broadening the spectrum of complications. Muscle Nerve 1999;22:404-7.
12. Rossi P, Fossaluzza V, Tosato F. Coexistence of Sjögren's syndrome associated systemic sclerosis with Adie's syndrome [letter]. J Rheumatol 1986;13:823-5.
13. Wright RA, Grant IA, Low PA. Autonomic neuropathy associated with sicca complex. J Auton Nerv Syst 1999;75:70-6.
14. Gemignani F, Manganelli P, Pavesi G, Marbini A. Polyneuropathy in Sjögren's syndrome: a case of prevalently autonomic neuropathy with tonic pupil and hypohidrosis. Funct Neurol 1988;3:337-48.
15. Andonopoulos AP, Ballas C. Autonomic cardiovascular neuropathy in primary Sjögren's syndrome. Rheumatol Int 1995;15:127-9.
16. Andonopoulos AP, Christodoulou J, Ballas C, Bounas A, Alexopoulos D. Autonomic cardiovascular neuropathy in Sjögren's syndrome: a controlled study. J Rheumatol 1998;25:2385-8.
17. Van de Merwe J, Kamerling R, Arendsen E, Mulder D, Hooijkaas H. Sjögren's syndrome in patients with interstitial cystitis. J Rheumatol 1993;20:962-6.
18. Buckley NJ, Caulfield M. Transmission: acetylcholine. In: Burnstock G, Hoyle CHV, editors. Autonomic neuroeffector mechanisms. Chur, Switzerland: Harwood Academic Publishers; 1992. p. 257-322.
19. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
20. Nakamura RM, Peebles CL, Rubin RL, Molder DP, Tan EM. Autoantibodies to nuclear antigens (ANA). 2nd ed. Chicago: American Society of Clinical Pathology Press; 1985.
21. Steinbuch M, Audran R. The isolation of IgG from mammalian sera with the aid of caprylic acid. Arch Biochem Biophys 1969; 134:279-84.
22. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998;17:1135-42.
23. Waterman SA. Multiple subtypes of voltage-gated calcium channel mediate transmitter release from parasympathetic neurons in the mouse bladder. J Neurosci 1996;16:4155-61.
24. Goin JC, Borda E, Perez Leiros C, Storino R, Sterin-Borda L. Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications. J Auton Nerv Syst 1994;47:45-52.
25. Magnusson Y, Marullo S, Hoyer S, Waagstein F, Andersson B, Vahlne A, et al. Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 1990;86:1658-63.
26. 1 receptor. J Clin Invest 1999;103:945-52.
27. Torres NE, Zollman PJ, Low PA. Characterization of muscarinic receptor subtype of rat eccrine sweat gland by autoradiography. Brain Res 1991;550:129-32.
28. Vilches JJ, Navarro X, Verdu E. Functional sudomotor responses to cholinergic agonists and antagonists in the mouse. J Auton Nerv Syst 1995;55:105-11.
29. Landis SC. Development of muscarinic receptors and regulation of secretory responsiveness in rodent sweat glands. Life Sci 1999;64: 381-5.
30. Ishizaka N, Noda M, Yokoyama S, Kawasaki K, Yamamoto M, Higashida H. Muscarinic acetylcholine receptor subtypes in the human iris. Brain Res 1998;787:344-7.
31. Bannister R, Hoyes AD. Generalised smooth-muscle disease with defective muscarinic-receptor function. Br Med J Clin Res Ed 1981;282:1015-8.
32. Dorffel WV, Felix SB, Wallukat G, Brehme S, Bestvater K, Hofmann T, et al. Short-term hemodynamic effects of immuno-adsorption in dilated cardiomyopathy. Circulation 1997;95:1994-7.
33. Barchan D, Souroujon MC, Sin-Hyeog I, Antozzi C, Fuchs S. Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor. Proc Natl Acad Sci U S A 1999;96:8086-91.